Shattuck Labs Inc (STTK)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $473.57M
Last updated: Nov 17, 2026 at 11:05 AM ET
Shattuck Labs Inc (STTK) Stock Forecast
Analysts expect Shattuck Labs (STTK) to earn -$0.55 per share in the fiscal year ending Dec 31, 2026, on revenue of $122220. Of 12 analysts, 12 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 5 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 25.0% |
| Buy | 9 | 75.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 12
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates are unchanged.
- Fiscal year ending Dec 31, 2026
- -$0.55
- EPS consensus, revenue $122220
- Fiscal year ending Dec 31, 2027
- -$0.58
- EPS consensus, revenue $122220
- Next report
- Mar 3, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.55 | -$1.13 to -$0.40 | 11 | $122220 | N/A | 9 |
| Dec 31, 2027 | -$0.58 | -$1.14 to -$0.37 | 11 | $122220 | N/A | 9 |
Quarterly Estimates
The EPS consensus rises from -$0.15 for the quarter ending Dec 31, 2026 to -$0.14 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.15 | -$0.25 to -$0.11 | 13 | $160283 | N/A | 10 |
| Mar 31, 2027 | -$0.14 | -$0.15 to -$0.12 | 5 | $60000 | N/A | 5 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 10 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 5 |
| Fiscal year ending Dec 31, 2027 | 1 | 4 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.41.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.55 | -$0.48 | -$0.48 | -$0.48 | -$0.41 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.58 | -$0.52 | -$0.53 | -$0.52 | -$0.44 | N/A |
| Quarter ending Mar 31, 2027 | -$0.14 | -$0.11 | -$0.12 | -$0.12 | -$0.11 | N/A |
Frequently Asked Questions About STTK
What is the STTK stock forecast?
Consensus analyst estimates put Shattuck Labs's EPS at -$0.55 for the fiscal year ending Dec 31, 2026, on revenue of $122220. The consensus rating from 12 analysts is Buy.
How do analysts rate STTK stock?
Of 12 analysts covering Shattuck Labs, 3 rate it Strong Buy, 9 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from STTK next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.55, with estimates from -$1.13 to -$0.40 from 11 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.58, with estimates from -$1.14 to -$0.37 from 11 analysts.
What revenue do analysts expect from Shattuck Labs next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $122220. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $122220.
How many analysts cover STTK?
12 analysts rate Shattuck Labs stock, and 11 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
STTK pages: Overview, Earnings, Forecast, Financials, Competitors